Araştırma Makalesi

Carnosol and carnosic acid may be a promising anticancer agent in non-small cell lung cancer treatment

Cilt: 49 Sayı: 1 29 Mart 2024
PDF İndir
EN TR

Carnosol and carnosic acid may be a promising anticancer agent in non-small cell lung cancer treatment

Abstract

Purpose: This study aimed to evaluate the possible anticancer and apoptotic effect of carnosol and carnosic acid on non-small cell lung cancer (NSCLC) cell lines in vitro. Materials and Methods: Three different NSCLC cell lines (H441, H520, and H661) were used in the study and treatment (carnosol and carnosic acid treatment) and control (no treatment) groups were established in all cell lines. The IC50 doses were determined by MTT method on NSCLC cell lines and the changes in expression levels of apoptosis-related genes (Bax, Bak, caspase-3, p53, c-Myc, Bcl-2, and Bcl-XL) were demonstrated by real-time polymerase chain reaction (qPCR), and apoptosis was confirmed by flow cytometry. The treatment group and control group results were compared. Results: The IC50 doses of carnosol and carnosic acid were determined; 60 µM for the H441, 20 µM for the H661, 40 µM for the H520, 20 µM for the H441, 40 µM for the H661, 40 µM for the H520, respectively. Carnosol treatment increased Bax, Bak, caspase-3, and p53 expression but decreased Bcl-XL expression in studied lung cancer cell lines. Carnosic acid treatment increased apoptotic Bax, Bak, caspase-3, and p53 expression but decreased antiapoptotic Bcl-2 and Bcl-XL expression (p<0.05). Conclusion: In this study showed that carnosol and carnosic acid have apoptotic effects on NSCLC cells. With more detailed studies on these agents, these come become a promising agent that can be used in NSCLC cancer treatment in the future.

Keywords

Apoptosis , carnosol , carnosic acid , rosemary , non-small lung cancer

Kaynakça

  1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7-30.
  2. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394-424.
  3. Ngo SN, Williams DB, Head RJ. Rosemary and cancer prevention: preclinical perspectives. Crit Rev Food Sci Nutr. 2011;51:946-54.
  4. Moore J, Yousef M, Tsiani E. Anticancer effects of rosemary (Rosmarinus officinalis L.) extract and rosemary extract polyphenols. Nutrients. 2016;8:731.
  5. Yesil-Celiktas O, Sevimli C, Bedir E, Vardar-Sukan F. Inhibitory effects of rosemary extracts, carnosic acid and rosmarinic acid on the growth of various human cancer cell lines. Plant Foods Hum Nutr. 2010;65:158-63.
  6. Johnson JJ. Carnosol: a promising anti-cancer and anti-inflammatory agent. Cancer Lett. 2011;305:1-7.
  7. Kalantar H, Sadeghi E, Abolnezhadian F, Goudarzi M, Hemmati AA, Basir Z, et al. Carnosol attenuates bleomycin-induced lung damage via suppressing fibrosis, oxidative stress and inflammation in rats. Life Sci. 2021;287:120059.
  8. Farhadi F, Baradaran Rahimi V, Mohamadi N, Askari VR. Effects of rosmarinic acid, carnosic acid, rosmanol, carnosol, and ursolic acid on the pathogenesis of respiratory diseases. Biofactors. 2023;49:478-501.
  9. Cattaneo L, Cicconi R, Mignogna G, Giorgi A, Mattei M, Graziani G, et al. Anti-proliferative effect of Rosmarinus officinalis L. extract on human melanoma A375 cells. PLoS One. 2015;10:e0132439.
  10. Kontogianni VG, Tomic G, Nikolic I, Nerantzaki AA, Sayyad N, Stosic-Grujicic S et al. Phytochemical profile of Rosmarinus officinalis and Salvia officinalis extracts and correlation to their antioxidant and anti-proliferative activity. Food Chem. 2013;136:120-9.

Kaynak Göster

MLA
Duran, Tuğçe, vd. “Carnosol and carnosic acid may be a promising anticancer agent in non-small cell lung cancer treatment”. Cukurova Medical Journal, c. 49, sy 1, Mart 2024, ss. 81-88, doi:10.17826/cumj.1399224.